Closing the pneumococcal conjugate vaccine (PCV) introduction gap: an archetype analysis of last-mile countries.

The current health and policy indicator-based categorisation provides an actionable framework to design tailored PCV advocacy within these last-mile countries. Policy approaches emerging from this framework can lead to strengthened decision-making on vaccine introduction and sustained vaccine access that can enhance child survival worldwide.